# Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma

> **NCT01507506** · PHASE3 · TERMINATED · sponsor: **Institut Claudius Regaud** · enrollment: 180 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **RADIATION:** Radiotherapy
- **RADIATION:** Experimental arm

## Key facts

- **NCT ID:** NCT01507506
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03-15
- **Primary completion:** 2020-01-02
- **Final completion:** 2020-01-02
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01507506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01507506, "Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01507506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*